Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?

Background and Objectives: An increasing number of patients (pts) with locally advanced pancreatic cancer (LAPC) are treated with an intensive neoadjuvant therapy to obtain a secondary curative resection. Only a certain number of patients benefit from this intention. The aim of this investigation wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosumeck, Nathalie, Timmermann, Lea, Klein, Fritz, Bahra, Marcus, Stintzig, Sebastian, Malinka, Thomas, Pelzer, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831047/
https://www.ncbi.nlm.nih.gov/pubmed/33477505
http://dx.doi.org/10.3390/medicina57010077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831047/
https://www.ncbi.nlm.nih.gov/pubmed/33477505
http://dx.doi.org/10.3390/medicina57010077

Ejemplares similares